PCI Group has been acquired by Verisk Analytics, Inc.
The private shareholders of the PCI Group have sold the company to Verisk Analytics, Inc. Financial details have not been disclosed.
The PCI Group is a consortium of five specialist companies, comprising PCI Xylenes & Polyesters Ltd, PCI Research GmbH (nylon, fibers and engineering plastics), PCI PET Packaging Resin & Recycling, PCI Films Consulting Ltd, RXN Petrochemical Consulting Inc., that work together to provide integrated data and subscriptions research in the chemicals, fibers, films nand plastics sectors.
Verisk Analytics is a leading source of information about risk. The company offers risk assessment services and decision analytics for professionals in many fields, including: property/casualty insurance, financial services, healthcare, energy, government and human resources. Verisk Analytics has its corporate headquarters in Jersey City, New Jersey, and offices throughout the United States and around the world.
Oaklins Cavendish, based in the UK, advised the seller in this transaction.
Talk to the deal team
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more